Phase II study of mFOLFIRINOX efficacy as first and subsequent lines of advanced gastrointestinal neuroendocrine tumors G3 and neuroendocrine carcinomas therapy. Phase 1b portion of the ACTION-1 phase ...
Objective To quantify the time lag between biomedical articles and the studies they describe as “recent,” a term widely used to imply timeliness despite rarely reflecting the actual age of the cited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback